Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial

sonderdruck aus: Trials | 2021

von Keitel-Anselmino, V. | Kern, W. | Ohmann, C.

A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): a structured summary of a study protocol for a randomised controlled trial

sonderdruck aus: Trials | 2020

von Rilinger, J. | Kern, W. | Dürschmied, D. | +4